Vancorp Pharmaceuticals Private Limited
About Vancorp Pharmaceuticals Private Limited
Data last updated:
Vancorp Pharmaceuticals Private Limited is a private limited company based in Noida, Uttar Pradesh, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 21 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U74999UP2018PTC108285. Its GSTIN is 09AAGCV6106P1ZR (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Shubham Rana and Vikas.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 289 First Floor Sector – Mu II Ghori Bachera Greater Noida, Uttar Pradesh, India – 201308.
As per the financials filed for FY 2025, the company reported a revenue of ₹49.64 Lakh, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹2.53 Lakh (net margin 5.1%) and EBITDA of ₹3.85 Lakh (EBITDA margin 7.8%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 12% over five years.
As per MCA filings, the company has open charges of ₹17.65 Lakh on record.
Company details
Contact details
Vancorp Pharmaceuticals Private Limited's registered office is in Noida, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address289 First Floor Sector – Mu II Ghori Bachera Greater Noida, Uttar Pradesh, India – 201308
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Vancorp Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Vancorp Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Vancorp Pharmaceuticals Private Limited, buy the company report.
Financials of Vancorp Pharmaceuticals Private Limited
FY 2025 filings availableVancorp Pharmaceuticals Private Limited reported revenue of ₹49.64 Lakh (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 3% growth in the latest year. EBITDA fell 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.85 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.53 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.8% | ||||
| Net Profit Margin | 5.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vancorp Pharmaceuticals Private Limited, buy the company report.
Board of directors of Vancorp Pharmaceuticals Private Limited
Vancorp Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shubham Rana Also directs: Skinarthur Pharmaceutical Private Limited | Director | 25 Feb 2019 | 7 Years 8 Months | Current |
| Vikas Also directs: Selvunix Pharmaceuticals Private Limited | Director | 21 Sep 2018 | 8 Years 1 Months | Current |
| Manoj Kumar Also directs: Skinarthur Pharmaceutical Private Limited | Director | 21 Sep 2018 | 8 Years 1 Months | Current |
Peer comparison
Vancorp Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Weizman Pharmaceuticals Private Limited | ₹49.87 Lakh (FY 2025) | 5.0% | Bahraich, Uttar Pradesh, India | |||
| Curenetic Pharmaceuticals Private Limited | ₹49.82 Lakh (FY 2025) | 8.0% | Noida, Uttar Pradesh, India | |||
| Xenomics Pharmaceuticals Private Limited | ₹49.71 Lakh (FY 2024) | 53.0% | Hyderabad, Telangana, India | |||
| Vancorp Pharmaceuticals Private Limitedthis company | ₹49.64 Lakh (FY 2025) | ₹2.53 Lakh | 5.1% | 3.0% | Noida, Uttar Pradesh, India | |
| Reinheit Pharmaceuticals Private Limited | ₹49.48 Lakh (FY 2024) | 132.0% | Kolkata, West Bengal, India | |||
| Olampus Pharmaceuticals Private Limited | ₹49.41 Lakh (FY 2024) | 9.0% | Patna, Bihar, India |
To see the full peer comparison of Vancorp Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Feb 2023 | 100703778 | Hdfc Bank Limited | ₹9.23 Lakh | Open | |
| 24 May 2021 | 100460441 | Hdfc Bank Limited | ₹8.42 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Vancorp Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vancorp Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Vancorp Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAGCV6106P1ZR | Uttar Pradesh | Active | 11 Feb 2019 |
To see the full GST registrations and return filing status of Vancorp Pharmaceuticals Private Limited, buy the company report.
Recent activity
Vancorp Pharmaceuticals Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Shubham Rana was appointed as Director on 25 Feb 2019.
Frequently asked questions
Vancorp Pharmaceuticals is an active private limited company based in Noida, Uttar Pradesh, India. The company works in other services, within the business services industry. It was incorporated on 21 September 2018 (8+ years old) and is registered under CIN U74999UP2018PTC108285.
Vancorp Pharmaceuticals has 3 current directors:
- Shubham Rana - Director
- Vikas - Director
- Manoj Kumar - Director
The latest financial statements of Vancorp Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Vancorp Pharmaceuticals is 09AAGCV6106P1ZR, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Vancorp Pharmaceuticals is U74999UP2018PTC108285. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vancorp Pharmaceuticals was incorporated on 21 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Vancorp Pharmaceuticals by revenue are Weizman Pharmaceuticals Private Limited, Curenetic Pharmaceuticals Private Limited, Xenomics Pharmaceuticals Private Limited, Reinheit Pharmaceuticals Private Limited, Olampus Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Shubham Rana was appointed as Director on 25 Feb 2019. Manoj Kumar was appointed as Director on 21 Sep 2018. Vikas was appointed as Director on 21 Sep 2018.
The registered office of Vancorp Pharmaceuticals is at 289 First Floor Sector – Mu II Ghori Bachera Greater Noida, Uttar Pradesh, India – 201308.
Vancorp Pharmaceuticals operates in the business services industry, in the other services segment.
Vancorp Pharmaceuticals has open charges of ₹17.65 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
